We are live on ! Find out more
EHWM

Eads & Heald Wealth Management Portfolio holdings

AUM $204M
1-Year Est. Return 28.27%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+28.27%
3 Year Est. Return
+84.36%
5 Year Est. Return
+119.71%
10 Year Est. Return
+418.36%
AUM
$202M
AUM Growth
+$5.26M
Cap. Flow
-$988K
Cap. Flow %
-0.49%
Top 10 Hldgs %
15.11%
Holding
150
New
5
Increased
43
Reduced
91
Closed
6

Top Buys

Rank Stock Value
1
COR icon
Cencora
COR
+$897K
2
CAT icon
Caterpillar
CAT
+$566K
3
GL icon
Globe Life
GL
+$347K
4
XOM icon
ExxonMobil
XOM
+$286K
5
ADI icon
Analog Devices
ADI
+$284K

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$464K
2
GWW icon
W.W. Grainger
GWW
+$437K
3
VRSK icon
Verisk Analytics
VRSK
+$285K
4
PFG icon
Principal Financial Group
PFG
+$279K
5
TFC icon
Truist Financial
TFC
+$268K

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Technology 17.35%
3 Industrials 15.23%
4 Consumer Staples 14.1%
5 Consumer Discretionary 12.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCK icon
101
Crown Holdings
CCK
$13.2B
$678K 0.34%
8,194
-1,195
-13% -$101K
MDLZ icon
102
Mondelez International
MDLZ
$80.1B
$652K 0.32%
9,345
-145
-2% -$9.6K
ADSK icon
103
Autodesk
ADSK
$51.2B
$623K 0.31%
2,993
+145
+5% +$29.9K
MTD icon
104
Mettler-Toledo International
MTD
$28.5B
$623K 0.31%
407
-25
-6% -$37.5K
PYPL icon
105
PayPal
PYPL
$51.1B
$594K 0.29%
7,828
-528
-6% -$40.7K
CBRE icon
106
CBRE Group
CBRE
$42.7B
$589K 0.29%
8,085
+1,930
+31% +$158K
MDT icon
107
Medtronic
MDT
$110B
$576K 0.29%
7,150
-863
-11% -$70.3K
FCX icon
108
Freeport-McMoran
FCX
$95.5B
$574K 0.28%
14,029
-780
-5% -$32.4K
AMCR icon
109
Amcor
AMCR
$21.8B
$534K 0.26%
9,390
-1,003
-10% -$57.4K
MRSH
110
Marsh
MRSH
$92.2B
$530K 0.26%
3,180
– –
IBM icon
111
IBM
IBM
$220B
$497K 0.25%
3,793
-173
-4% -$23.1K
PFE icon
112
Pfizer
PFE
$149B
$490K 0.24%
12,000
+4,518
+60% +$195K
CRM icon
113
Salesforce
CRM
$153B
$484K 0.24%
2,421
-205
-8% -$34.6K
MRK icon
114
Merck
MRK
$317B
$482K 0.24%
4,526
+44
+1% +$4.75K
PCAR icon
115
PACCAR
PCAR
$69.5B
$470K 0.23%
6,427
+410
+7% +$29.3K
T icon
116
AT&T
T
$162B
$445K 0.22%
23,137
-295
-1% -$5.64K
CRL icon
117
Charles River Laboratories
CRL
$12.7B
$425K 0.21%
2,105
-746
-26% -$169K
MKC icon
118
McCormick & Company Non-Voting
MKC
$14.1B
$399K 0.2%
4,790
-350
-7% -$26.7K
MS icon
119
Morgan Stanley
MS
$336B
$388K 0.19%
4,423
+110
+3% +$10.3K
MA icon
120
Mastercard
MA
$505B
$370K 0.18%
1,017
+107
+12% +$38.9K
CI icon
121
Cigna
CI
$72.7B
$362K 0.18%
1,418
+126
+10% +$36.7K
ITT icon
122
ITT
ITT
$19.2B
$350K 0.17%
4,055
-246
-6% -$21.6K
C icon
123
Citigroup
C
$224B
$326K 0.16%
6,958
-25
-0.4% -$1.23K
GILD icon
124
Gilead Sciences
GILD
$162B
$307K 0.15%
3,705
+375
+11% +$31.1K
RMD icon
125
ResMed
RMD
$32.4B
$302K 0.15%
1,380
– –
2 3 4
5
6

Similar funds

CAM
Concorde Asset Management Ann Arbor, Michigan $204M AUM
KFA
Kapstone Financial Advisors Lebanon, Ohio $204M AUM 22.12% 1-Year Est. Return
II
Ironclad Investments Maitland, Florida $204M AUM 16.26% 1-Year Est. Return
AA
Aufman Associates Sewickley, Pennsylvania $204M AUM 39.64% 1-Year Est. Return
WA1
Wimmer Associates 1 Pasadena, California $205M AUM 21.23% 1-Year Est. Return
OF
Optimize Financial Laguna Hills, California $203M AUM 57.91% 1-Year Est. Return
TCM
TAM Capital Management Stamford, Connecticut $205M AUM 28.94% 1-Year Est. Return
PKC
Palmer Knight Company Jacksonville, Florida $205M AUM 9.86% 1-Year Est. Return

Eads & Heald Wealth Management's Q1 2023 Portfolio in Review

As of Q1 2023, Eads & Heald Wealth Management held 150 positions worth $202M, up 2.7% from $197M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Eads & Heald Wealth Management's Q1 2023 filing shows 5 new, 43 increased, 91 reduced and 6 closed positions. Its largest new stake was Organon & Co: 8,830 shares worth $208K. The largest sale was Intel, an estimated $464K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

  • Eads & Heald Wealth Management's largest Q1 2023 buy was Organon & Co: 8,830 shares worth $208K.
  • Eads & Heald Wealth Management added most to Cencora in Q1 2023, an estimated $897K increase.
  • Eads & Heald Wealth Management's biggest Q1 2023 reduction was W.W. Grainger, cutting an estimated $437K.
  • Eads & Heald Wealth Management fully exited Intel in Q1 2023, selling an estimated $464K.
  • Eads & Heald Wealth Management's ten largest holdings make up 15% of its $202M portfolio in Q1 2023.
  • Eads & Heald Wealth Management opened 5 new positions and closed 6 in Q1 2023.
  • Eads & Heald Wealth Management's portfolio value rose 2.7% quarter-over-quarter to $202M.

Based on Eads & Heald Wealth Management's 13F filing for Q1 2023, filed 21 Apr 2023.